| Mr Christopher M Mueller, DPT | |
|
821 Us Highway 81 W, New Braunfels, TX 78130-5741 | |
| (210) 912-7537 | |
| Not Available |
| Full Name | Mr Christopher M Mueller |
|---|---|
| Gender | Male |
| Speciality | Physical Therapist |
| Location | 821 Us Highway 81 W, New Braunfels, Texas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063904563 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 1305297 (Texas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mr Christopher M Mueller, DPT 821 Us Highway 81 W, New Braunfels, TX 78130-5741 Ph: (210) 912-7537 | Mr Christopher M Mueller, DPT 821 Us Highway 81 W, New Braunfels, TX 78130-5741 Ph: (210) 912-7537 |
News Archive
Telesta Therapeutics Inc. announced today that it has submitted electronically, through its U.S. agent, a Biologics License Application (BLA) to the United States Food and Drug Administration for MCNA. MCNA is Telesta's novel biologic immunotherapeutic for the treatment of high-risk non-muscle invasive bladder cancer patients who have failed first-line BCG therapy.
RedHill Biopharma Ltd. (NASDAQ; RDHL) (TASE: RDHL) ("RedHill" or the "Company"), a biopharmaceutical company primarily focused on development and commercialization of late clinical-stage, proprietary, orally-administered, small molecule drugs for inflammatory and gastrointestinal diseases, including cancer, today announced that it has initiated a randomized, double-blind, 2-arm parallel group Phase II clinical study in the U.S. evaluating the safety and efficacy of BEKINDA™ 12 mg in patients with diarrhea-predominant irritable bowel syndrome (IBS-D).
To investigate the immune memory sustainability of SARS-CoV-2-specific B cells and T cells, stimulated by the inactivated vaccine, and the potential need for a third booster dose in healthcare workers (HCWs), a non-randomized trial was undertaken by researchers at Sun Yat-sen University in Guangzhou, China. the research is posted online on the medRxiv* preprint server.
Federal scientists have developed a vaccine that protects mice against the killer 1918 influenza virus. They also have created a technique for identifying antibodies that neutralize this virus, a tool that could help contain future pandemic flu strains.
HeadSense, an early stage company developing a non-invasive neurological monitor focused initially on an intracranial pressure application, today announced it closed financing led by Pontifax, a leading Israeli VC; GE Ventures of Menlo Park, California, USA; Everett Partners, an investment group based out of Akron, Ohio, USA; and JuMaJo, an investment group from Hamburg, Germany.
› Verified 6 days ago
Nancy Patten, Physical Therapist Medicare: Medicare Enrolled Practice Location: 2166 Ranch Loop Dr, New Braunfels, TX 78132 Phone: 830-237-5527 | |
Gruene Therapy Services, Pllc Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1067 Fm 306 Ste 608, New Braunfels, TX 78130 Phone: 737-344-0245 | |
Mrs. Katie Elizabeth Halliburton, P.T. Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 1528 E Common St, Ste 23, New Braunfels, TX 78130 Phone: 830-620-4922 Fax: 830-625-1194 | |
Jessica Mendoza, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 272 Fm 306 Ste 122, New Braunfels, TX 78130 Phone: 830-500-5300 Fax: 830-500-5350 | |
Aimee Moreau Anthony, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1324 Common St, Suite 307, New Braunfels, TX 78130 Phone: 830-625-7310 | |
Mr. Francisco Yap Jr., PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 2056 Sundance Pkwy Apt 7207, New Braunfels, TX 78130 Phone: 716-335-4998 |